| 02/14 | Canadian pot producer Canopy may face challenges offloading assets, CEO says | RE |
| 02/14 | FTSE 100 ends week lower after week AstraZeneca, RBS results | RE |
| 02/14 | Merck's Zaire Ebolavirus Vaccine Registered in Four African Countries | DJ |
| 02/14 | ICON PUBLIC LIMITED COMPANY : annual earnings release | |
| 02/14 | SONIC HEALTHCARE LIMITED : half-yearly earnings release | |
| 02/14 | ELANCO ANIMAL HEALTH INCORPORATED : annual earnings release | |
| 02/14 | ALLERGAN : Form 8.3 - | DJ |
| 02/14 | ABBVIE : Form 8.3 - | DJ |
| 02/14 | AstraZeneca braces for coronavirus hit, but no impact so far | RE |
| 02/14 | AstraZeneca's CEO reaffirms 2021 targets | RE |
| 02/14 | ASTRAZENECA : 4Q Core Operating Profit Tumbled, Expects Growth in 2020 | DJ |
| 02/14 | Bayer Touts Herbicide Research Discovery -- WSJ | DJ |
| 02/13 | BAXTER INTERNATIONAL : Expects Restatement to Cut Income From Continuing Operations | DJ |
| 02/13 | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP DAVIDSON KEMPNER CAPITAL MANAGEMENT LP : Form 8.3 - Allergan Plc | DJ |
| 02/13 | ALLERGAN : Form 8.3 - | DJ |
| 02/13 | ABBVIE : Form 8.3 - | DJ |
| 02/13 | AMEDISYS, INC. : annual earnings release | |
| 02/13 | CHEMED CORPORATION : annual earnings release | |
| 02/13 | COCHLEAR LIMITED : half-yearly earnings release | |
| 02/13 | STRAUMANN HOLDING : annual earnings release | |
| 02/13 | SARTORIUS : annual earnings release | |
| 02/13 | AGILENT TECHNOLOGIES, INC. : quaterly earnings release | |
| 02/13 | MEDTRONIC PLC : quaterly earnings release | |
| 02/13 | MEDTRONIC : to Acquire Digital Surgery for Undisclosed Amount | DJ |
| 02/13 | BRISTOL MYERS SQUIBB : Myers Gets FDA Priority Review for Lisocabtagene Maraleucel in Large B-Cell Lymphoma | DJ |
| 02/13 | ZOETIS' : Adjusted Earnings, Revenue for 4Q Beat Analysts' Expectations | DJ |
| 02/13 | ZOETIS' : Adjusted Earnings Guidance for 2020 Is Short of Analysts' Estimates | DJ |
| 02/13 | Technically solid | |
| 02/13 | INDIVIOR : posts steep quarterly loss as copycat drugs bite, shares plunge | RE |
| 02/13 | Bayer Seeks to Settle Cases, Keep Roundup -- WSJ | DJ |
| 02/13 | CVS Reaps Benefits of Aetna Deal -- WSJ | DJ |
| 02/12 | Bayer Strives to End Lawsuits Over Roundup -- While Still Selling It | DJ |
| 02/12 | Coronavirus-Drug Development Becomes a Top Focus at Gilead | DJ |
| 02/12 | GILEAD SCIENCES : Correction to Report About Gilead Sciences' Work on a Coronavirus Drug | DJ |
| 02/12 | CVS Swings to Profit, Forecasts 2020 Results in Line With Estimates -- Update | DJ |
| 02/12 | Gilead Sciences Scrambles to Supply Experimental Coronavirus Drug | DJ |
| 02/12 | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP DAVIDSON KEMPNER CAPITAL MANAGEMENT LP : Form 8.3 - Allergan Plc | DJ |
| 02/12 | ALLERGAN : Form 8.3 - | DJ |
| 02/12 | ABBVIE : Form 8.3 - | DJ |
| 02/12 | LYSOGENE : annual sales release | |
| 02/12 | CVS HEALTH : Names Lotvin as President of CVS Caremark | DJ |
| 02/12 | CVS HEALTH : Turns Quarterly Profit, Posts Higher Revenue | DJ |
| 02/12 | MERCK : Keytruda Combo Meets Main Endpoint in Metastatic Triple-Negative Breast Cancer | DJ |
| 02/12 | Underpinned by a support level | |
| 02/12 | The underlying trend is to the upside | |
| 02/11 | JOHNSON & JOHNSON : J&J's Janssen to Work With HHS on Accelerating Coronavirus Vaccine | DJ |
| 02/11 | CSL : 1st Half Net Profit Rises, Upgrades Full-Year Guidance | DJ |
| 02/11 | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP DAVIDSON KEMPNER CAPITAL MANAGEMENT LP : Form 8.3 - Allergan Plc | DJ |
| 02/11 | ALLERGAN : Form 8.3 - Allergan Plc | DJ |
| 02/11 | ABBVIE : Form 8.3 -AbbVie Inc. -2- | DJ |
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
